<DistDoc action="rep" dist="dist_id" distdocver="05.1" an="WSJO000020180320ee3k00714" doctype="article"><SelectData><FolderName id="302210958" rl="100">WSJ</FolderName></SelectData><ReplyItem lang="en"><BaseLang value="en" fid="la"/><IPDocId fid="id">0F7961A5227F76B649436298C529307F SB12440397079396364614404584111493063373198</IPDocId><AccessionNo value="WSJO000020180320ee3k00714" fid="an"/><Num value="571" fid="wc"/><Date value="20180320" fid="pd"/><Time value="223400" fid="et"/><SrcCode value="wsjo" fid="sc"/><SrcName fid="sn">The Wall Street Journal Online</SrcName><TruncRules><XS value="25"/><S value="60"/><M value="75"/></TruncRules><Title fid="hl"><SectionName fid="se">Opinion</SectionName><ColumnName fid="clm"></ColumnName><Headline fid="hd"><Para lang="en">A GOP Right-To-Try Fumble; House Republicans may kill a bill to give cancer patients a choice.</Para></Headline></Title><Snippet><Para>President Trump has never been accused of being a policy wonk, but now and then he fixates on a good idea, and one has been the "right to try" experimental drug therapies still seeking approval by the Food and Drug Administration. The ...</Para></Snippet><Byline fid="by">By The Editorial Board </Byline><Credit fid="cr"></Credit><Copyright fid="cy">Copyright 2018 Dow Jones &amp; Company, Inc. All Rights Reserved. </Copyright><CodeSets><CSet fid="co"><Code value="usfda"/></CSet><CSet fid="in"><Code value="i257"/><Code value="i951"/></CSet><CSet fid="re"><Code value="namz"/><Code value="usa"/></CSet><CSet fid="ns"><Code value="gpol"/><Code value="gvlwh"/><Code value="c23"/><Code value="gcat"/><Code value="ghea"/><Code value="gpir"/><Code value="gvbod"/><Code value="nedc"/><Code value="nedi"/><Code value="ctrial"/><Code value="ccat"/><Code value="gvcng"/><Code value="ncat"/><Code value="nfact"/><Code value="nfcpex"/></CSet></CodeSets></ReplyItem><MetadataPT><DocData><DocType value="article" fid="fmt"/><IPDocId fid="id">0F7961A5227F76B649436298C529307F SB12440397079396364614404584111493063373198</IPDocId><AccessionNo value="WSJO000020180320ee3k00714" fid="an"/><Num value="571" fid="wc"/><Num value="2638" fid="cc"/><Date value="20180320" fid="pd"/><Date value="20180320" fid="upd"/><Date value="20180321" fid="md"/><Time value="223400" fid="et"/><Time value="223413" fid="upt"/><Time value="181057" fid="mt"/><BaseLang value="en" fid="la"/><Editor value="" fid="rve"/><RevisionNo value="2" fid="rvn"/></DocData><PubData><Restrictor fid="rst"><Code value="FSPNORMAWS0300"/><Code value="WSJO"/><Code value="fspFileId275200649"/><Code value="FUT"/><Code value="CLNTALL"/><Code value="CTGSMFS"/><Code value="CTGWSJ"/><Code value="DEEPWSJP"/><Code value="EN"/><Code value="IBNK"/><Code value="IFINAL"/><Code value="IINV"/><Code value="NAMZ"/><Code value="SFWSJ"/><Code value="TBAC"/><Code value="TBED"/><Code value="TBIZ"/><Code value="TBRK"/><Code value="TDJP"/><Code value="TDJWMNP"/><Code value="TFCDLIC"/><Code value="TFIN"/><Code value="TIAS"/><Code value="TIBMNB"/><Code value="TIMG"/><Code value="TINT"/><Code value="TIOP"/><Code value="TMNB"/><Code value="TMNBUS"/><Code value="TNPS"/><Code value="TNWP"/><Code value="TNWPN"/><Code value="TOPUSA"/><Code value="TSCH"/><Code value="TTRD"/><Code value="TTRK"/><Code value="TUSN"/><Code value="TWMSA"/><Code value="TYAS"/><Code value="TYLA"/><Code value="USA"/><Code value="fspWebpage"/><Code value="MPCV1M9M1B1"/><Code value="MPCEnvPROD"/><Code value="MPCDocHash9B5A8DE07469B0FB"/><Code value="FSP2YESCOOC"/><Code value="FSP2YESCOORGOC"/><Code value="FSPRBC"/><Code value="FSPRBCCO"/><Code value="FSPRBCORG"/><Code value="FSP2YESCO"/><Code value="FSP2YESCOORG"/><Code value="FSPRBCIN"/><Code value="FSP2YESIN"/><Code value="FSPCATEGORIZER"/><Code value="FSPCATNS"/><Code value="FSPRBCNS"/><Code value="FSP2YESNS"/><Code value="FSPRBCRE"/><Code value="FSP2YESRE"/><Code value="FSP2YESPEOC"/><Code value="FSPRBC579860"/><Code value="FSPRBC648020"/><Code value="FSPRBC698693"/><Code value="FSPRBC788780"/><Code value="FSPRBC789635"/><Code value="FSPRBC799599"/><Code value="FSPRBC800069"/><Code value="FSPRBC802123"/><Code value="FSPRBC812638"/><Code value="FSPRBC829299"/><Code value="FSPRBC830746"/><Code value="FSPRBC831127"/><Code value="FSPRBC849172"/><Code value="FSPRBC849536"/><Code value="FSPRBC857522"/><Code value="FSPRBC860177"/><Code value="FSPRBC860258"/><Code value="FSPRBC860259"/><Code value="FSPRBC860298"/><Code value="FSPRBC860312"/><Code value="FSPRBC860380"/><Code value="FSPRBC860404"/><Code value="FSPRBC861461"/><Code value="FSPRBC861689"/><Code value="FSPRBC861918"/><Code value="MPCCL"/><Code value="MPCJP"/><Code value="MPCKW"/><Code value="MPCKP"/><Code value="MPCESRE"/><Code value="MPCESIN"/><Code value="MPCESNS"/><Code value="FSP2AC"/></Restrictor><IPId value="DJENT" fid="ip"/><PublisherN fid="pub">Dow Jones &amp; Company, Inc.</PublisherN><AttribCode value="WSJO2" fid="atr"/><SrcCode value="WSJO" fid="sc"/><SrcName fid="sn">The Wall Street Journal Online</SrcName><Logo img="wsjoLogo.gif" link="" src="http://logos.factiva.com"/></PubData><CodeSets><CSet fid="co"><Code value="usfda"><CodeD index="no" lang="en">U.S. Food and Drug Administration</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="698693"/><CodeA name="db" value="prbc---00018568-20180321-074612"/><CodeA name="rule" value="579860"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI></Code></CSet><CSet fid="in"><Code value="i257"><CodeD index="no" lang="en">Pharmaceuticals</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="648020"/><CodeA name="db" value="prbc---00018568-20180321-074612"/><CodeA name="rule" value="802123"/><CodeA name="rule" value="831127"/><CodeA name="rule" value="849536"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="1"/></CodeI></Code><Code value="i951"><CodeD index="no" lang="en">Health Care/Life Sciences</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="861918"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="in:i257"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="0"/></CodeI></Code></CSet><CSet fid="re"><Code value="namz"><CodeD index="no" lang="en">North America</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="861461"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="re:usa"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="usa"><CodeD index="no" lang="en">United States</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="698693"/><CodeA name="db" value="prbc---00018568-20180321-074612"/><CodeA name="rule" value="861689"/><CodeA name="rule" value="579860"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="1"/></CodeI></Code></CSet><CSet fid="ns"><Code value="gpol"><CodeD index="no" lang="en">Domestic Politics</CodeD><CodeI org="categoriser" action="add"><CodeA name="db" value="es-EnglishNS_en_20180316142643"/><CodeA name="es_score" value="310"/></CodeI><CodeI org="rbc" action="add"><CodeA name="rule" value="799599"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:gvlwh"/><CodeA name="root" value="ns:gvbod"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="2"/></CodeI></Code><Code value="gvlwh"><CodeD index="no" lang="en">Lower House</CodeD><CodeI org="categoriser" action="add"><CodeA name="db" value="es-EnglishNS_en_20180316142643"/><CodeA name="es_score" value="300"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="5"/></CodeI></Code><Code value="c23"><CodeD index="no" lang="en">Research/Development</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="860404"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:ctrial"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="1"/></CodeI></Code><Code value="gcat"><CodeD index="no" lang="en">Political/General News</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="860298"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:gpol"/><CodeA name="root" value="ns:gvlwh"/><CodeA name="root" value="ns:ghea"/><CodeA name="root" value="ns:gpir"/><CodeA name="root" value="ns:gvbod"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="ghea"><CodeD index="no" lang="en">Health</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="860312"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="1"/></CodeI></Code><Code value="gpir"><CodeD index="no" lang="en">Politics/International Relations</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="860380"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:gpol"/><CodeA name="root" value="ns:gvlwh"/><CodeA name="root" value="ns:gvbod"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="1"/></CodeI></Code><Code value="gvbod"><CodeD index="no" lang="en">Government Bodies</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="860177"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:gvlwh"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="3"/></CodeI></Code><Code value="nedc"><CodeD index="no" lang="en">Commentaries/Opinions</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="812638"/><CodeA name="db" value="prbc---00018568-20180321-074612"/><CodeA name="rule" value="788780"/><CodeA name="rule" value="789635"/><CodeA name="rule" value="829299"/><CodeA name="rule" value="830746"/><CodeA name="rule" value="849172"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI></Code><Code value="nedi"><CodeD index="no" lang="en">Editorials</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="860258"/><CodeA name="db" value="prbc---00018568-20180321-074612"/><CodeA name="rule" value="860259"/><CodeA name="rule" value="857522"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI></Code><Code value="ctrial"><CodeD index="no" lang="en">New Product/Service Testing</CodeD><CodeI org="rbc" action="add"><CodeA name="rule" value="800069"/><CodeA name="db" value="prbc---00018568-20180321-074612"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="2"/></CodeI></Code><Code value="ccat"><CodeD index="no" lang="en">Corporate/Industrial News</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:c23"/><CodeA name="root" value="ns:ctrial"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="0"/></CodeI></Code><Code value="gvcng"><CodeD index="no" lang="en">Legislative Branch</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:gvlwh"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI><CodeI org="hierarchy" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="nodelevel" value="4"/></CodeI></Code><Code value="ncat"><CodeD index="no" lang="en">Content Types</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:nedc"/><CodeA name="root" value="ns:nedi"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI></Code><Code value="nfact"><CodeD index="no" lang="en">Factiva Filters</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:nedc"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI></Code><Code value="nfcpex"><CodeD index="no" lang="en">C&amp;E Executive News Filter</CodeD><CodeI org="expansion" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="root" value="ns:nedc"/></CodeI><CodeI org="validation" action="add"><CodeA name="db" value="pedv---00000997-20180320-161217"/><CodeA name="status" value="active"/></CodeI></Code></CSet></CodeSets><DescTPC fid="de"><DescField fid="ipc">G/FDA G/IGV M/HCR N/EDC N/EDI N/GEN N/HLT N/PLT N/RND R/NME R/US </DescField><DescField fid="ipd">WSJ.com WSJ.com Site Search WSJAsia WSJEurope WSJ Japanese Online WSJ-PRO-WSJ.com SB124403970793963646144045841114930633731981 Walden, Greg SYND CODES_REVIEWED Review &amp; Outlook (U.S.) </DescField><DescField fid="ipcns">OPIN </DescField></DescTPC></MetadataPT><ArchiveDoc xml:space="preserve"><Article markup="pp0" lang="en" index="field"><HandL fid="hlp"><Title fid="hl"><SectionName fid="se" index="field">Opinion</SectionName><ColumnName fid="clm" index="field"></ColumnName><Headline fid="hd"><Para lang="en">A GOP Right-To-Try Fumble; House Republicans may kill a bill to give cancer patients a choice.</Para></Headline></Title><LeadPara fid="lp"><Para>President Trump has never been accused of being a policy wonk, but now and then he fixates on a good idea, and one has been the "right to try" experimental drug therapies still seeking approval by the Food and Drug Administration. The question is why a GOP Congress is bungling this ostensible White House priority.</Para><Para>Last week a "right to try" bill failed 259-140 in the House, which tried to pass the measure on a suspension procedure that requires a two-thirds majority. Democrats opposed the measure, which in essence says: If a very ill patient wants to roll the dice on a drug that has not been declared effective by FDA, government will not interfere. The drug must have cleared Phase I trials for safety.</Para></LeadPara></HandL><TailParas fid="td"><Para>The House may try to pass the bill again with a simple majority, but the failure is the result of several months of political malpractice. The Senate passed a right-to-try bill last August. Wisconsin Senator Ron Johnson's proposal had 46 co-sponsors, including two Democrats, and passed by unanimous consent. The old joke is that bills go to the Senate to die but here the House is the graveyard thanks to Energy and Commerce Chairman Greg Walden.</Para><Para>One debate has been who could qualify as eligible to try experimental drugs, which companies aren't compelled to provide. For instance: Does a patient have to be terminally ill? The Johnson bill opened up the avenue for a patient with a "life-threatening" condition who has exhausted all other options. Mr. Walden narrowed eligibility modestly after months of Socratic contemplation.</Para><Para>Either definition would be an incremental improvement for patients. Opponents of right-to-try tend to cite FDA's "compassionate use" program that grants nearly all petitions for a physician to treat a patient with an unapproved therapy. The process has been streamlined in recent years. Most physicians will continue to go through the agency, which can inform decisions such as proper dosage. Nothing in the bill touches the FDA program.</Para><Para>But right-to-try hedges against a future FDA that could be hostile to patient choice. That is easy to imagine as Democrats threaten price controls or single payer. It's also important as a statement of intent from Congress, and pressure on FDA to speed up drug approvals is increasing.</Para><Para>Remarkably, right-to-try could die. The House may include its version in the omnibus spending bill, but Democrats will demand changes that may weaken it to the point of futility. If the House passes the Walden bill separately, the legislation would have to clear the Senate—again. One Senator could hold up the bill, which is probable now that right-to-try has attracted opposition from House Democrats. The solution is obvious: The House should pass the Johnson bill and send it to Mr. Trump, who by all accounts is waiting to sign it.</Para><Para>One of our readers captured the urgency in <ELink type="webpage" ref="https://www.wsj.com/articles/a-trial-drug-may-have-helped-my-late-daughter-1518209834">a letter to the editor last month</ELink> about a daughter who in the late 1990s tried to petition FDA to receive a new drug in testing. "She was denied permission and died just as Gleevec was being approved," Terry Holland of California wrote. "It turned out to be hugely successful for her type of cancer."</Para></TailParas><Byline fid="by" index="field">By The Editorial Board </Byline><Credit fid="cr" index="field"></Credit><Contact fid="ct" index="field"></Contact><Notes fid="rf" index="field"></Notes><Art fid="art" index="field"></Art><Copyright fid="cy" index="field">Copyright 2018 Dow Jones &amp; Company, Inc. All Rights Reserved. </Copyright></Article></ArchiveDoc><AdocTOC adoctype="article"><Item size="0" ref="distdoc:archive/ArchiveDoc::Article" type="arttext"></Item><Item size="0" ref="distdoc:archive/InvertText" type="invtext"></Item><Item subtype="primary" size="0" ref="https://www.wsj.com/articles/a-gop-right-to-try-fumble-1521585243" type="webpage"></Item></AdocTOC></DistDoc>

